$SER 4 SEC Filings

Filed On	Filing
23 Jul 2026	Form 4: Simon Farrell, Director Granted 30,500 Stock Option (right to buy)
09 Jul 2026	Form 4: Brannan Stephen K., Director Bought 1,000 shares ($2.03K)
22 Jun 2026	Form 4: Venkatesan Jay, Director Bought 589 shares ($1.05K) · Received 224,152 shares by conversion ($504K) · Granted 15,250 Stock Option (right to buy)
22 Jun 2026	Form 4: Bailey Gregory, Director Received 8,437,472 shares by conversion ($19M) · Granted 15,250 Stock Option (right to buy) · Granted 3,333,333 Redeemable Warrants
22 Jun 2026	Form 4: Brannan Stephen K., Director Granted 15,250 Stock Option (right to buy)
22 Jun 2026	Form 4: Wilson Karen J, Director Granted 15,250 Stock Option (right to buy)
22 Jun 2026	Form 4: Marshall Richard Peter, Director Granted 15,250 Stock Option (right to buy)
15 Jun 2026	Form 4: Wilson Karen J, Director Bought 5,100 shares ($8.9K) · Bought 5,000 shares ($8.85K)
27 May 2026	Form 4: Ledger Steven A, Director Received 10,100 shares as a grant or award ($19.5K)
26 May 2026	Form 4: Tenjarla Srini, SVP, CMC & Formulation Granted 85,558 Stock Option (right to buy)
26 May 2026	Form 4: Ledger Steven A, Director Granted 380,825 Stock Option (right to buy)
26 May 2026	Form 4: Curhan Gregory S, Chief Financial Officer Granted 123,019 Stock Option (right to buy)
26 May 2026	Form 4: Moreadith Randall, Chief Scientific Officer Granted 85,558 Stock Option (right to buy)
26 May 2026	Form 4: Wilson Karen J, Director Bought 10,000 shares ($17.7K) · Bought 10,000 shares ($19.3K)
22 May 2026	Form 4: Marshall Richard Peter, Director Bought 12,183 shares ($20.1K)
21 Apr 2026	Form 4: Bailey Gregory, Director Received 59,667 shares as a grant or award ($116K)
21 Apr 2026	Form 4: Venkatesan Jay, Director Received 7,553 shares as a grant or award ($14.7K)
24 Mar 2026	Form 4: Moreadith Randall, Chief Scientific Officer Received 6,500 shares by exercise or conversion ($390) · Sold 6,500 shares ($18.6K)
20 Mar 2026	Form 4: Moreadith Randall, Chief Scientific Officer Received 39,000 shares by exercise or conversion ($2.34K) · Sold 39,000 shares ($97.5K)
17 Feb 2026	Form 4: Tenjarla Srini, SVP, CMC & Formulation Granted 69,000 Stock Option (right to buy)

Comments